Results 71 to 80 of about 162,965 (256)

Imaging Studies of Aging, Neurodegenerative Disease, and Alcoholism. [PDF]

open access: yes, 1995
Neurodegenerative diseases such as Alzheimers disease, disorders such as alcoholism, and the aging process can lead to impaired cognitive function and dementia.
Eberling, Jamie, JAGUST, William J
core  

Staff-led interventions for improving oral hygiene in patients following stroke [PDF]

open access: yes, 2010
Background For people with limitations due to neurological conditions such as stroke, the routine practice of oral care may become a challenge. Evidence-based supported oral care intervention is essential for this patient group. Objectives To compare the
Brady, Marian C.   +4 more
core   +3 more sources

Inherited metabolic epilepsies–established diseases, new approaches

open access: yesEpilepsia Open, EarlyView.
Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley   +1 more source

Anesthetic management of a child with Hunter′s syndrome

open access: yesJournal of Anaesthesiology Clinical Pharmacology, 2012
Hunter′s syndrome is a member of a group of recessively inherited metabolic disorders termed mucopolysaccharidoses, caused by deficiency of lysosomal enzymes required for degradation of mucopolysaccharides or glycosaminoglycans, leading to accumulation ...
Jasmeet Kaur   +3 more
doaj   +1 more source

Epileptic drop attacks: More than just atonic seizures

open access: yesEpilepsia Open, EarlyView.
Abstract “Drop attacks” are not officially defined by the International League Against Epilepsy. Seizures are characterized by a sudden loss of control over the trunk and posture, leading to falls and injuries, and resolving within a few seconds. Accurately diagnosing the type of seizure is usually difficult due to limitations in clinical documentation
Tomonori Ono   +3 more
wiley   +1 more source

Hunter Syndrome [PDF]

open access: yes, 2020
Justin Rich   +2 more
  +4 more sources

MUCOPOLYSACCHARIDOSIS TYPE II

open access: yesПедиатрическая фармакология, 2011
Article is devoted to one of the orphan diseases — mucopolysaccharidosis (MPS), which is the result of any lysosomal enzyme deficiency (which determines the type of illness). The most common is the MPS type II (Hunter syndrome), developing as a result of
N.D. Vashakmadze   +6 more
doaj   +2 more sources

Intracranial findings of Hunter syndrome [PDF]

open access: yesPediatric Radiology, 2010
A 13-year-old boy presented with mental retardation, progressive hearing loss and coarsened facial features. Brain MRI demonstrated punctate and oblong CSF-equivalent cystic areas within the corpus callosum, basal ganglia and periventricular white matter (Figs. 1 and 2), with surrounding hyperintensity on T2-W and FLAIR images (Fig. 1).
Ramesh S, Iyer, Paritosh C, Khanna
openaire   +2 more sources

Older Adults at Risk for Atrial Fibrillation Lack Knowledge and Confidence to Seek Treatment for Signs and Symptoms. [PDF]

open access: yes, 2017
Early detection of atrial fibrillation (AF) is crucial for averting AF-related stroke and heart failure, but treatment is delayed when AF is not recognized.
Barton, Debra L   +2 more
core   +2 more sources

Systematic review: Safety and efficacy of atomoxetine in children and adolescents with autism spectrum disorder

open access: yesJCPP Advances, EarlyView.
This systematic review aimed to assess the current evidence on the efficacy and safety of Atomoxetine in common clinical symptoms of autism spectrum disorder (ASD) for children and adolescents. With limited studies available, there is a need for more high‐power studies for the use of Atomoxetine in children and adolescents with autism spectrum disorder.
Nihit Gupta   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy